Skip to content
Home/Companies/Pharma/Fagron
Fagron

Fagron

Pharma·Belgium·Exited 2019·Held 3yr
Entry
2016
Hold
3yr
Exit
2019

Who owns Fagron?

Fagron is a Belgian Pharma company, formerly owned by Waterland Private Equity, exited in 2019 (exit via Secondary). No current private equity owner is on file.

Hand-verified · updated 2026-08-11

Open JSON · CC-BY
Waterland Private Equity
Investor
Waterland Private Equity
Waterland Private Equity Fund VI (WPEF VI) · 2015 · Buyout

Key facts

HQBelgium
SectorPharma
StatusAcquired
Websitefagron.com
Exit Type
Secondary
Exit Year
2019

More from Waterland Private Equity Fund VI (WPEF VI)

Other portfolio companies in the same fund.

compassio
compassio
Active
HealthcareGermany· 2017
EMPWR (Vitamin Well Group)
Exited 2026
FoodTechBelgium· 2017
to Vitamin Well Group
EMPWR Nutrition Group
Exited 2026
FoodTechBelgium· 2017
to Vitamin Well Group
Enhesa
Enhesa
Exited 2020
LegalTechBelgium· 2017
to CGE Partners
Nuts Groep
Active
EnergyNetherlands· 2017
Zentrum der Gesundheit
Zentrum der Gesundheit
Exited 2019
HealthTechGermany· 2017
to NORD Holding

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Fagron?

Fagron was formerly owned by Waterland Private Equity, exited in 2019. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue